Published on 27 Mar 2024 on GuruFocus.com via Yahoo Finance
ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares
Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the company on March 27, 2024, according to a recent SEC filing. The transaction was executed at an average price of $17.9 per share, resulting in a total value of $316,880.60.
ACADIA Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company has a portfolio of products aimed at a range of conditions including Parkinson's disease psychosis, schizophrenia, and major depressive disorder.